|
Bv-AVD-R 1 and 2: COHORT IIa Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Intermediate Risk cohort IIa
Birmingham, Alabama1 trial
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
University of Alabama
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.